Author

Eric Lai

Institution: VentureWell

Observed institution: VentureWell

ORCID: 0000-0001-5850-7451

Observed ORCID: 0000-0001-5850-7451

OpenAlex ID: A5122779035

A Method for Variant Agnostic Detection of SARS-CoV-2, Rapid Monitoring of Circulating Variants, and Early Detection of Emergent Variants Such as Omicron

2022 · Eric Lai, David Becker, et al. · Journal of Clinical Microbiology · 21

Performance Evaluation of the Xpert® HCV Test on Fingerstick Blood in a Prospective Observational Clinical Study at CLIA-Waived Sites in the United States

2026 · Jennifer R Havens, Shelly-Ann Fluker, et al. · Clinical Infectious Diseases · 2

Independent Testing to Accelerate the Development of Lateral Flow Assays for Influenza A, Influenza B and SARS-COV-2

2025 · Anuradha Rao, Laura Johnson, et al. · Clinical Infectious Diseases · 2

151. Detection of highly pathogenic avian influenza A(H5N1) in contrived nasal swab specimens using commercial molecular influenza A tests

2026 · Anuradha Rao, Leda Bassitt, et al. · Open Forum Infectious Diseases

P-1985. Multi-pathogen screening of lesion swab specimens submitted for clinical testing at a national reference laboratory

2026 · Anuradha Rao, Courtney Sabino, et al. · Open Forum Infectious Diseases

Works count: 5

Citation count: 25

H-index: 2

I10-index: 1